The correct application of cardiac biomarkers helps to clarify diagnoses, avoid missed and misdiagnoses, and is crucial for the early identification of heart diseases such as acute coronary syndrome (ACS). The detection of myocardial biomarkers aids in the timely initiation of effective treatment, reducing complications and saving patients' lives. Cardiac biomarkers include cardiac troponin (cTn), B-type natriuretic peptide (BNP), and C-reactive protein (CRP), which are ideal risk stratification markers and play a very important role in clinical treatment guidance and monitoring. The detection of myocardial biomarkers can accurately and promptly reflect myocardial damage, which is significant for early diagnosis and prognostic assessment.
Pair
Lot
Product name
Classes
Method
Application
TRIAL
XJ260
Lp-PLA2 antibody
Ab
Lp-PLA4 double antibody sandwich method
Mark
XJ259
Lp-PLA2 antibody
Ab
Lp-PLA3 double antibody sandwich method
Package
XJ256
ST2 antibody
Ab
ST2 double antibody sandwich method
Mark
XJ257
ST2 antibody
Ab
ST2 double antibody sandwich method
Package
XJ243
D-Dimer antibody
Ab
D-Dimer double antibody sandwich method
Mark
XJ241
D-Dimer antibody
Ab
D-Dimer double antibody sandwich method
Package
XJ236
H-FABP antibody
Ab
H-FABP double antibody sandwich method
Mark
XJ237
H-FABP antibody
Ab
H-FABP double antibody sandwich method
Package
XJ220
NT-ProBNP antibody
Ab
NT-ProBNP double antibody sandwich method
Mark
XJ29
NT-ProBNP antibody
Ab
NT-ProBNP double antibody sandwich method
Package
XJ23
CTNT antibody refers to an antibody that targets cardiac troponin T (CTNT), a protein found in cardiac muscle. This antibody is often used in research and clinical settings to detect heart muscle damage or to study cardiac function.
Ab
cTnT double antibody sandwich method
Mark
XJ221
CTNT antibody refers to an antibody that targets cardiac troponin T (CTNT), a protein found in cardiac muscle. This antibody is often used in research and clinical settings to detect heart muscle damage or to study cardiac function.
